The company registered standalone net profits after tax of EGP 43.559 million in Q1 2025, compared to EGP 2.046 million in ...

Andrew Witty is a business executive well-known for his contributions to the Pharmaceutical and health sectors.

A number of records 'tumbled' as an annual race in memory of a south Cumbrian athlete returned. The Paul Jarvis Mile was organised by the Hoad Hill Harriers and took place on May 8 near Glaxo Sports ...

With a neutral sentiment as of May 8, 2025, according to Moneycontrol analysis, GlaxoSmithKline Pharmaceuticals demonstrates ...

Witty began his career as a management trainee at Glaxo UK in 1985 and went on to hold several international leadership roles ...

Helen Thomas was the European editor for Heard on the Street, based in London.

DRUG giants were put on notice by Donald Trump yesterday that he would be slashing prices for medicines in the US to the cheapest available. The move is another blow for Britain’s drug giants ...

Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The relentless pressures on public health institutions have forced consumers to think more about self-medication, says Warren ...

US President Donald Trump today hailed a 'great' trade deal that will "open up" the UK. And it will. Like an oyster.

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...